JPRN-UMIN000005242招募中3 期
Efficacy and safety of low dose mycophenolate mofetile for remission maintenance in ANCA-associated vasculitis - Low dose mycophenolate mofetile as maintenance therapy in ANCA-associated vasculitis
Department of Medicine, Kidney Center, Tokyo Women's Medical University0 个研究点目标入组 20 人开始时间: 2011年5月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •WBC<3000/mm3 pregnant women combine with other immunosuppressant within 4 weeks
研究者
相似试验
进行中（未招募）
1 期
Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay immunosuppression in comparison to current standard immunosuppression (mycophenolate mofetil, tacrolimus and continued corticosteroids) in renal transplantation. - UK ELiTERenal TransplantationMedDRA version: 7.1Level: PTClassification code 10038533EUCTR2004-005055-33-GBBarts and the London NHS Trust
已完成
不适用
Safety and efficacy of mycophenolate mofetil in pediatric renal transplantatioISRCTN89278733Erasmus Medical Center (The Netherlands)44
尚未招募
4 期
Study comparing the ability of two medications, namely oral tablets of mycophenolate mofetil and cyclophosphamide, in keeping disease well controlled in patients with frequently relapsing or steroid dependent nephrotic syndromeCTRI/2022/10/046891AIIMS New Delhi
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitisEUCTR2006-001663-33-DECambridge University Hospitals NHS Foundation Trust140
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitis. Wegener´s granulomatosis (WG) and microscopic polyangiitis (MPA) are primary systemic vasculitides associated with ANCAEUCTR2006-001663-33-SECambridge University Hospitals NHS Foundation Trust140